Scientists have identified a new regulator of the innate immune response—the immediate, natural immune response to foreign invaders. The study suggests that therapeutics that modulate the regulator—an immune checkpoint—may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments for autoimmune disease.
More détails